|
Dealing in securities by a director and a prescribed officer of the company
ATTACQ LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1997/000543/06)
JSE share code: ATT ISIN: ZAE000177218
(Approved as a REIT by the JSE)
("Attacq" or "the company")
DEALING IN SECURITIES BY A DIRECTOR AND PRESCRIBED OFFICER OF THE COMPANY
Shareholders are advised of the following information relating to the award of conditional performance
shares ("CPSs") and acceptance thereof by a director and prescribed officer under the Attacq Limited Long-
Term Incentive Plan ("LTIP") which are subject to various performance conditions set and agreed by the
Remuneration and Nominations Committee, in line with the strategic objectives of the company, together
with the award of retention shares and acceptance thereof by a director and prescribed officer under the
LTIP, which awards are not subject to performance conditions. These awards will vest in three tranches on
a 60%, 20%, 20% basis in 3, 4 and 5 years' time respectively.
Name of director: Jackie van Niekerk
Transaction date: 14 September 2021
Class of security: Options over ordinary shares
Number of securities: 500 000
Price per security R7.00
Total value: R3 500 000.00
Nature of transaction: Award of retention shares in terms of the LTIP
Nature and extent of director's interest Direct beneficial
Clearance to deal obtained: Yes
Name of director: Jackie van Niekerk
Transaction date: 14 September 2021
Class of security: Options over ordinary shares
Number of securities: 500 000
Price per security R7.00
Total value: R3 500 000.00
Nature of transaction: Allocation of CPSs in terms of the LTIP
Nature and extent of director's interest Direct beneficial
Clearance to deal obtained: Yes
Name of prescribed officer: Michael Clampett
Transaction date: 14 September 2021
Class of security: Options over ordinary shares
Number of securities: 100 000
Price per security R7.00
Total value: R700 000.00
Nature of transaction: Award of retention shares in terms of the LTIP
Nature and extent of director's interest Direct beneficial
Clearance to deal obtained: Yes
Name of prescribed officer: Michael Clampett
Transaction date: 14 September 2021
Class of security: Options over ordinary shares
Number of securities: 100 000
Price per security R7.00
Total value: R700 000.00
Nature of transaction: Allocation of CPSs in terms of the LTIP
Nature and extent of director's interest Direct beneficial
Clearance to deal obtained: Yes
16 September 2021
Sponsor
Java Capital
Date: 16-09-2021 04:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
| Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information. | |||||||||
| Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site | |||||||||
| [ Terms of Use | Privacy Policy | PAIA manual | FAQs/Help | Site Map | © Copyright Reserved 2026 ] | |||||||||
|
|||||||||
